Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pak Fah Yeow InternationalHKSE:00239 80 Shareholder Yield % is 2.79% as of Dec. 2025, which is 36% below its 10-year median of 4.39. GuruFocus rates HKSE:00239 with a GF Score™ of 80/100 and a GF Value™ of HK$2.17 (Fairly Valued). The stock has 3 warning signs investors should review. Among 974 Drug Manufacturers companies, Pak Fah Yeow International ranks better than 69.51% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Pak Fah Yeow International's Shareholder Yield % was 2.79%.
Pak Fah Yeow International (HKSE:00239) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Pak Fah Yeow International Shareholder Yield % Related Terms
Pak Fah Yeow International Shareholder Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pak Fah Yeow International Shareholder Yield % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Pak Fah Yeow International's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pak Fah Yeow International Shareholder Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pak Fah Yeow International's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Pak Fah Yeow International's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Pak Fah Yeow International (HKSE:00239) has a Shareholder Yield % of 2.79% as of Dec. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Pak Fah Yeow International and its competitors. This is 36% below median its historical median of 4.39. Over the past decade, Pak Fah Yeow International's Shareholder Yield % has ranged from 2.69 to 6.75. According to the industry distribution chart, Pak Fah Yeow International ranks #297 out of 974 companies in the Drug Manufacturers industry, placing it in the top 30.5%.
Is Pak Fah Yeow International's Shareholder Yield % too high?
Pak Fah Yeow International's current Shareholder Yield % of 2.79% is 36% below median its 10-year median of 4.39. Over the past 10 years, this metric has ranged from a low of 2.69 to a high of 6.75. The Drug Manufacturers industry median Shareholder Yield % is 0.32. Pak Fah Yeow International's value of 2.79% is 785.7% above this industry median. Based on the distribution chart, Pak Fah Yeow International ranks #297 out of 974 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Pak Fah Yeow International has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pak Fah Yeow International's Shareholder Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Pak Fah Yeow International ranks #297 out of 974 companies for Shareholder Yield %. This puts Pak Fah Yeow International in the upper half of its industry. The industry median Shareholder Yield % is 0.32. Pak Fah Yeow International's value of 2.79% is 785.7% above this benchmark. Historically, Pak Fah Yeow International's own Shareholder Yield % has ranged from 2.69 to 6.75 over the past decade. While the company's 10-year median is 4.39 vs. the industry median of 0.32, Pak Fah Yeow International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Drug Manufacturers company?
The median Shareholder Yield % among Drug Manufacturers companies is 0.32, based on 974 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pak Fah Yeow International's current Shareholder Yield % of 2.79% is 785.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Pak Fah Yeow International and its competitors. For the Drug Manufacturers industry, the median Shareholder Yield % is 0.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pak Fah Yeow International's current Shareholder Yield % is 2.79%, which is 36% below median its own 10-year median of 4.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pak Fah Yeow International stock overvalued right now?
Based on GuruFocus' analysis, Pak Fah Yeow International (HKSE:00239) is currently considered Fairly Valued. The stock's GF Value™ is HK$2.17, compared to a current price of HK$2.38 — trading 9.4% above its estimated fair value. The current Shareholder Yield % is 2.79%, which is 36% below median its 10-year median of 4.39 and 785.7% above the Drug Manufacturers industry median of 0.32. Pak Fah Yeow International's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Pak Fah Yeow International (HKSE:00239), the current Shareholder Yield % is 2.79% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pak Fah Yeow International (HKSE:00239) Overvalued in 2026?
Based on GuruFocus' analysis, Pak Fah Yeow International stock appears to be overvalued.
The current stock price of HK$2.38 is trading 9.4% above its estimated GF Value™ of HK$2.17.
GuruFocus considers Pak Fah Yeow International to be Fairly Valued.
Key valuation signals for HKSE:00239:
Shareholder Yield %: 2.79% (36% below median its 10-year median of 4.39)
GF Value™: HK$2.17 vs. price of HK$2.38 (9.4% above fair value)
Industry Position: 785.7% above the Drug Manufacturers median (#297 of 974)
No single metric tells the full story. See the HKSE:00239 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pak Fah Yeow International Ltd, with its subsidiaries, is engaged in the manufacture and distribution of healthcare products, including Hoe Hin branded products. It also engages in real estate investment and treasury investment businesses. It has three business segments, namely healthcare, property investments, and treasury investments. The Company derives the majority of its revenues from the Healthcare segment.The Groups businesses cover Hong Kong, Macau, other regions in the Peoples Republic of China (the PRC or Chinese Mainland), Southeast Asia, North America and the United Kingdom.
80GF Score
Get the complete analysis for HKSE:00239
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00239 has been successfully added to your 
